Invention Grant
US08455196B2 Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
有权
用于鉴定早期肺腺癌患者亚组的生物标志物
- Patent Title: Biomarker for identifying subgroup of early-stage lung adenocarcinoma patients
- Patent Title (中): 用于鉴定早期肺腺癌患者亚组的生物标志物
-
Application No.: US13478835Application Date: 2012-05-23
-
Publication No.: US08455196B2Publication Date: 2013-06-04
- Inventor: Jin-Mei Lai
- Applicant: Jin-Mei Lai
- Agency: WPAT, P.C.
- Agent Anthony King
- Main IPC: C12Q1/68
- IPC: C12Q1/68
Abstract:
The preset invention relates to a biomarker for identifying the subgroup of early-stage lung adenocarcinoma patients in early-stage non-small cell lung cancer (NSCLC), which is T-lymphokine-activated killer cell-originated protein kinase (TOPK), and a therapeutic target for lung cancer.
Public/Granted literature
- US20120302624A1 BIOMARKER FOR IDENTIFYING SUBGROUP OF EARLY-STAGE LUNG ADENOCARCINOMA PATIENTS Public/Granted day:2012-11-29
Information query
